AlphaQ Advisors LLC Acquires Shares of 3,265 HealthEquity, Inc. (NASDAQ:HQY)

AlphaQ Advisors LLC purchased a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 3,265 shares of the company's stock, valued at approximately $313,000. HealthEquity makes up approximately 0.9% of AlphaQ Advisors LLC's portfolio, making the stock its 26th biggest position.

Several other large investors have also recently modified their holdings of HQY. Arcadia Investment Management Corp MI purchased a new position in shares of HealthEquity in the fourth quarter worth $26,000. Transce3nd LLC purchased a new stake in shares of HealthEquity during the 4th quarter valued at about $29,000. Smartleaf Asset Management LLC increased its position in HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after acquiring an additional 98 shares during the last quarter. Proficio Capital Partners LLC purchased a new position in shares of HealthEquity during the 4th quarter worth $39,000. Finally, UMB Bank n.a. grew its position in shares of HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company's stock valued at $40,000 after acquiring an additional 164 shares during the period. Hedge funds and other institutional investors own 99.55% of the company's stock.

Insider Transactions at HealthEquity

In related news, EVP Michael Henry Fiore sold 8,881 shares of the company's stock in a transaction on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the sale, the executive vice president now owns 56,655 shares of the company's stock, valued at $4,433,820.30. This represents a 13.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction dated Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the completion of the sale, the director now owns 84,969 shares in the company, valued at approximately $6,597,842.85. This trade represents a 6.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.50% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the company. Barrington Research reiterated an "outperform" rating and set a $112.00 target price on shares of HealthEquity in a research report on Friday, April 11th. KeyCorp decreased their price objective on HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and cut their price objective for the company from $120.00 to $115.00 in a research note on Tuesday, March 25th. Royal Bank of Canada started coverage on shares of HealthEquity in a research note on Thursday. They issued an "outperform" rating and a $112.00 price objective for the company. Finally, Wells Fargo & Company lifted their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research note on Wednesday, February 26th. One analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, HealthEquity has an average rating of "Buy" and a consensus price target of $112.33.

HealthEquity Price Performance

NASDAQ HQY traded down $1.07 on Monday, reaching $99.01. The company had a trading volume of 908,113 shares, compared to its average volume of 808,012. The firm's 50 day moving average price is $88.03 and its 200 day moving average price is $97.40. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $115.59. The stock has a market capitalization of $8.56 billion, a PE ratio of 90.83, a price-to-earnings-growth ratio of 1.60 and a beta of 0.45. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.